Literature DB >> 17576498

Spanish language translation of pelvic floor disorders instruments.

Amy E Young1, Paul M Fine, Rebecca McCrery, Patricia A Wren, Holly E Richter, Linda Brubaker, Morton B Brown, Anne M Weber.   

Abstract

The purpose of the study is to translate existing measures of pelvic symptoms and quality of life from English into Spanish, facilitating research participation of Hispanic/Latina women. The forward-backward translation protocol was applied then adjudicated by a concordance committee. The measures included the Pelvic Floor Distress Inventory (PFDI), Pelvic Floor Impact Questionnaire (PFIQ), Medical, Epidemiological, and Social Aspects of Aging (MESA) Questionnaire, Hunskaar Severity Measure, Fecal Incontinence Severity Index and modified Manchester Questionnaire, Pelvic Organ Prolapse/Urinary Incontinence Sexual Functioning Questionnaire (PISQ), and the Life Orientation Test (LOT). English and Spanish versions were administered to 50 Hispanic/Latina women with pelvic symptoms. Kappa correlations of items and correlation coefficients for scales were computed. Psychometric testing for translations demonstrated good (0.80-0.89), very good (0.90-0.95), or excellent (>0.95) correlations for primary scales of the PFDI, PFIQ, MESA, Hunskaar, PISQ, and LOT. Strict translation techniques and testing yielded valid Spanish translations of instruments assessing pelvic symptoms/functional life impact in women with pelvic floor disorders.

Entities:  

Mesh:

Year:  2007        PMID: 17576498     DOI: 10.1007/s00192-006-0297-1

Source DB:  PubMed          Journal:  Int Urogynecol J Pelvic Floor Dysfunct


  16 in total

1.  Trends in birth across high-parity groups by race/ethnicity and maternal age.

Authors:  Muktar H Aliyu; Hamisu M Salihu; Louis G Keith; John E Ehiri; M Aminul Islam; Pauline E Jolly
Journal:  J Natl Med Assoc       Date:  2005-06       Impact factor: 1.798

2.  Patient and surgeon ranking of the severity of symptoms associated with fecal incontinence: the fecal incontinence severity index.

Authors:  T H Rockwood; J M Church; J W Fleshman; R L Kane; C Mavrantonis; A G Thorson; S D Wexner; D Bliss; A C Lowry
Journal:  Dis Colon Rectum       Date:  1999-12       Impact factor: 4.585

3.  [The Spanish version of the SF-36 Health Survey (the SF-36 health questionnaire): an instrument for measuring clinical results].

Authors:  J Alonso; L Prieto; J M Antó
Journal:  Med Clin (Barc)       Date:  1995-05-27       Impact factor: 1.725

4.  Optimism, coping, and health: assessment and implications of generalized outcome expectancies.

Authors:  M F Scheier; C S Carver
Journal:  Health Psychol       Date:  1985       Impact factor: 4.267

5.  The prevalence of urinary incontinence among community dwelling adult women: results from the National Health and Nutrition Examination Survey.

Authors:  Jennifer Tash Anger; Christopher S Saigal; Mark S Litwin
Journal:  J Urol       Date:  2006-02       Impact factor: 7.450

6.  Differences in prevalence of urinary incontinence by race/ethnicity.

Authors:  David H Thom; Stephen K van den Eeden; Arona I Ragins; Christina Wassel-Fyr; Eric Vittinghof; Leslee L Subak; Jeanette S Brown
Journal:  J Urol       Date:  2006-01       Impact factor: 7.450

7.  A new condition-specific health-related quality of life questionnaire for the assessment of women with anal incontinence.

Authors:  G J Bug; E S Kiff; G Hosker
Journal:  BJOG       Date:  2001-10       Impact factor: 6.531

8.  Pelvic Organ Support Study (POSST): the distribution, clinical definition, and epidemiologic condition of pelvic organ support defects.

Authors:  Steven Swift; Patrick Woodman; Amy O'Boyle; Margie Kahn; Michael Valley; Deirdre Bland; Wei Wang; Joe Schaffer
Journal:  Am J Obstet Gynecol       Date:  2005-03       Impact factor: 8.661

9.  Validation of a Spanish version of the Pelvic Organ Prolapse Incontinence Sexual Questionnaire.

Authors:  Audrey A Romero; Anne Hardart; William Kobak; Clifford Qualls; Rebecca Rogers
Journal:  Obstet Gynecol       Date:  2003-11       Impact factor: 7.661

10.  Validation of a severity index in female urinary incontinence and its implementation in an epidemiological survey.

Authors:  H Sandvik; S Hunskaar; A Seim; R Hermstad; A Vanvik; H Bratt
Journal:  J Epidemiol Community Health       Date:  1993-12       Impact factor: 3.710

View more
  5 in total

1.  Spanish translation and validation of four short pelvic floor disorders questionnaires.

Authors:  Alejandro D Treszezamsky; Deborah Karp; Madeline Dick-Biascoechea; Nazanin Ehsani; Christina Dancz; T Ignacio Montoya; Cedric K Olivera; Aimee L Smith; Rosa Cardenas; Tola Fashokun; Catherine S Bradley
Journal:  Int Urogynecol J       Date:  2012-09-14       Impact factor: 2.894

2.  Validation of Spanish versions of the Pelvic Floor Distress Inventory (PFDI) and Pelvic Floor Impact Questionnaire (PFIQ): a multicenter validation randomized study.

Authors:  Tola B Omotosho; Anne Hardart; Rebecca G Rogers; Joseph I Schaffer; William H Kobak; Audrey A Romero
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-02-12

3.  Translation and psychometric evaluation of the Greek short forms of two condition-specific quality of life questionnaires for women with pelvic floor disorders: PFDI-20 and PFIQ-7.

Authors:  Themos Grigoriadis; Stavros Athanasiou; George Giannoulis; Sylvia-Christina Mylona; Dionysia Lourantou; Aris Antsaklis
Journal:  Int Urogynecol J       Date:  2013-06-19       Impact factor: 2.894

4.  A quantitative approach to measure women's sexual function using electromyography: a preliminary study of the Kegel exercise.

Authors:  Mas Sahidayana Mohktar; Fatimah Ibrahim; Nur Farahana Mohd Rozi; Juhaida Mohd Yusof; Siti Anom Ahmad; Khong Su Yen; Siti Zawiah Omar
Journal:  Med Sci Monit       Date:  2013-12-13

5.  Validation of a Spanish Version of the Prolapse and Incontinence Knowledge Questionnaire.

Authors:  Keila S Muñiz; Koraima Cedeño; Kathryn A Carson; Prerna R Pandya; Jacqueline Kikuchi; Danielle Patterson; Joan Blomquist; Stephanie Jacobs; Grace Chen Chi Chiung
Journal:  Female Pelvic Med Reconstr Surg       Date:  2021-11-01       Impact factor: 2.091

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.